PLASMA AND CEREBROSPINAL-FLUID CONCENTRATIONS OF INDOMETHACIN IN HUMANS - RELATIONSHIP TO ANALGESIC ACTIVITY

被引:53
作者
BANNWARTH, B
NETTER, P
LAPICQUE, F
PERE, P
THOMAS, P
GAUCHER, A
机构
[1] UNIV NANCY, FAC MED, PHARMACOL LAB, BOITE POSTALE 184, F-54505 VANDOEUVRE LES NANCY, FRANCE
[2] UNIV NANCY, FAC MED, RHUMATOL CLIN, F-54505 VANDOEUVRE LES NANCY, FRANCE
[3] HOP BEAUREGARD, SERV RHUMATOL, THIONVILLE, FRANCE
关键词
analgesic activity; cerebrospinal fluid; indomethacin; pharmacokinetics; protein binding;
D O I
10.1007/BF00315572
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Plasma and cerebrospinal fluid (CSF) concentrations of indomethacin have been determined in 52 patients hospitalized for nerve-root compression pain. Samples of blood and CSF were collected at the same time in each subject, 0.5 to 12 h after a single intramuscular injection of 50 mg indomethacin. Analgesic effect was assessed by the absolute and percentage variation in Huskisson's visual analogue scale between dosing and sampling. According to its high lipid solubility, indomethacin rapidly crossed the blood-brain barrier, being detected in CSF 0.5 h after administration. After attainment of equilibrium within 2 h, the CSF level exceeded the free plasma level. Since the drug was extensively bound to serum albumin (99.7±0.1%), this phenomenon may represent a slight degree of binding of indomethacin in CSF. The analgesic activity was not related to either the plasma or CSF concentration of indomethacin. © 1990 Springer-Verlag.
引用
收藏
页码:343 / 346
页数:4
相关论文
共 23 条
  • [1] PROTEIN-BINDING OF CHLORPROMAZINE IN CEREBROSPINAL-FLUID AND SERUM
    ALFREDSSON, G
    SEDVALL, G
    [J]. INTERNATIONAL PHARMACOPSYCHIATRY, 1980, 15 (05): : 261 - 269
  • [2] ALVAN G, 1975, CLIN PHARMACOL THER, V18, P364
  • [3] SENSITIVE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC DETERMINATION OF INDOMETHACIN IN HUMAN-PLASMA - PHARMACOKINETIC STUDIES AFTER SINGLE ORAL DOSE
    ASTIER, A
    RENAT, B
    [J]. JOURNAL OF CHROMATOGRAPHY, 1982, 233 (DEC): : 279 - 288
  • [4] BANNWARTH B, 1986, J RHEUMATOL, V13, P993
  • [5] CLINICAL PHARMACOKINETICS OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS IN THE CEREBROSPINAL-FLUID
    BANNWARTH, B
    NETTER, P
    POUREL, J
    ROYER, RJ
    GAUCHER, A
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 1989, 43 (02) : 121 - 126
  • [6] CLINICAL PHARMACOKINETICS OF CEREBROSPINAL-FLUID
    BONATI, M
    KANTO, J
    TOGNONI, G
    [J]. CLINICAL PHARMACOKINETICS, 1982, 7 (04) : 312 - 335
  • [7] BRUNE K, 1985, HDB INFLAMMATION, V5
  • [8] CLINICAL-PHARMACOLOGY OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS
    DAY, RO
    GRAHAM, GG
    WILLIAMS, KM
    CHAMPION, GD
    DEJAGER, J
    [J]. PHARMACOLOGY & THERAPEUTICS, 1987, 33 (2-3) : 383 - 433
  • [9] CENTRAL AND PERIPHERAL ANTI-ALGESIC ACTION OF ASPIRIN-LIKE DRUGS
    FERREIRA, SH
    LORENZETTI, BB
    CORREA, FMA
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1978, 53 (01) : 39 - 48
  • [10] FERREIRA SH, 1985, HDB INFLAMMATION, V5